Home/Database/HGH Fragment 176-191
Weight ManagementActive Research

HGH Fragment 176-191

Human Growth Hormone Fragment 176-191

16 Amino Acids · MW: 1817.12 g/mol

Ask AI About This

Amino Acids

16

Molecular Weight

1817.12 g/mol

Half-life

~30 minutes

Research Score

78.0

Studies

45

Storage

-20°C lyophilized, 2-8°C reconstituted

What is HGH Fragment 176-191?

HGH Fragment 176-191 is the fat-reducing portion of the growth hormone molecule, shown to be 12.5x more potent than regular GH for fat loss while having no effect on blood sugar or cell proliferation.

Key Benefits & Mechanisms

Targeted fat loss, no blood sugar impact, no IGF-1 elevation, inhibits lipogenesis, stimulates lipolysis, improved body composition

Research Summary

This 16-amino-acid fragment specifically targets adipose tissue via beta-3 adrenergic receptors. Works through a GH-receptor-independent pathway, explaining selective fat-loss properties without growth-promoting effects.

Related Peptides

Ipamorelin

Growth Hormone Secretagogue

Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GHRPs available.

Performance

CJC-1295

Growth Hormone Releasing Hormone Analog

CJC-1295 is a modified GHRH analog with an extended half-life due to Drug Affinity Complex (DAC) technology. It promotes sustained, pulsatile GH release, improving body composition, recovery, and sleep quality.

Performance

AOD-9604

Anti-Obesity Drug (Modified GH Fragment)

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 177-191) specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or tissue growth, making it a targeted fat-loss peptide without typical GH side effects.

Metabolic

Oxyntomodulin

Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide

Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.

Weight Management